BTIG raises Roblox stock price target to $73, maintains Buy rating
BTIG analyst Clark Lampen adjusted the price target for Roblox Corp . (NYSE:RBLX) shares, raising it to $73 from the previous $66, while maintaining a Buy rating on the stock. The reevaluation ...
BTIG maintains Coya Therapeutics stock buy rating, $15 target
BTIG analysts upheld their Buy rating and $15.00 price target for Coya Therapeutics (NASDAQ:COYA), following recent clinical trial data. The stock, currently trading at $7.11, has shown strong ...
BTIG says Paysafe could be worth $40 in sale, sees suitors as strategic buyers
BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article ...
BTIG cuts Lightspeed target, says shares ‘very washed out’
BTIG analyst Andrew Harte lowered the firm’s price target on Lightspeed (LSPD) to $17 from $21 and keeps a Buy rating on the shares. The shares ...
IQVIA (NYSE:IQV) Cut to “Neutral” at BTIG Research
BTIG Research lowered shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com reports. Several other ...
The TRADE1d
BTIG and OptimX partner on buy-side focused offering
This partnership addresses the growing demand among institutional traders for advanced, centralised technology that enables ...
Why Treace Medical Concepts (TMCI) Is Rallying Today
Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently ...
TMCnet2d
BTIG to Host Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 11 - 12, 2025
BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday, February 12, 2025. The firm expects ...